Wuhan Yiyi Tongguan Enterprise Management Partnership (Limited Partnership) and Hubei Qingsong Yueyue Pharmaceutical Co., Ltd. agreed to acquire 35% stake in Hubei Tianji Pharmaceutical Co., Ltd. from Xiangxue Pharmaceutical Co.,Ltd. (SZSE:300147) for CNY 385 million on June 30, 2022. Wuhan Yiyi Tongguan Enterprise will acquire 15% stake and Hubei Qingsong Yueyue Pharmaceutical will acquire additional 20% stake in Hubei Tianji Pharmaceutical. The board of Xiangxue Pharmaceutical approved the deal.

Hubei Tianji Pharmaceutical has reported net profit of CNY 81.5366 million on December 31, 2021.